Vascular graft infections in the intensive care unit: Clinical spectrum and prognostic factors

Journal of Infection

Volumn 62, Issue 3, 2011, Pages 204-211

  Szczot, Magdalena ^a   Meybeck, Agnès ^a   Legout, Laurence ^a   Pasquet, Armelle ^a   Van Grunderbeeck, Nicolas ^a   Langlois, Joachim ^a   Sarraz Bournet, Béatrice ^a   Devos, Patrick ^b   Leroy, Olivier ^a  

^a Hopital Dron   (France)

^b Faculté de Médecine Pôle Recherché   (France)

Author keywords

Infection; Intensive care; Prothetic; Vascular

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; FRESH FROZEN PLASMA; GENTAMICIN; LINEZOLID; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT;

AGED; ANTIBIOTIC THERAPY; AORTA DISEASE; AORTOINTESTINAL FISTULA; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLEEDING; BLOOD CULTURE; BLOOD VESSEL GRAFT; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROBACTERIACEAE; ERYTHROCYTE TRANSFUSION; FEMALE; FUNGUS; GRAFT INFECTION; GRAM POSITIVE COCCI; HUMAN; INTENSIVE CARE UNIT; ISCHEMIA; LENGTH OF STAY; MALE; METABOLIC DISORDER; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; RESPIRATORY FAILURE; SEPSIS; SHOCK; STAPHYLOCOCCUS; SURVIVOR; THROMBOCYTE TRANSFUSION; THROMBOSIS;

AGED; AGED, 80 AND OVER; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MYCOSES; SURGICAL WOUND INFECTION; SURVIVAL ANALYSIS; VASCULAR GRAFTING;

EID: 79952157109     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.12.006     Document Type: Article

References (32)

1. Fitzgerald S.F., Kelly C., Humphreys H. Diagnosis and treatment of prosthetic aortic graft infections: confusion and inconsistency in the absence of evidence or consensus?. J Antimicrob Chemother 2005, 56:996-999.
2. Darouiche R.O. Treatment of infections associated with surgical implants. N Engl J Med 2004, 350:1422-1429.
3. Homer-Vanniasinkam S. Surgical site and vascular infections: treatment and prophylaxis. Int J Infect Dis 2007, 11:S17-S22.
4. Oderich G.S., Bower T.C., Cherry K.J., Panneton J.M., Sullivan T.M., Noel A.A., et al. Evolution from axillofemoral to in situ prosthetic reconstruction for treatment of aortic graft infections at a single center. J Vasc Surg 2006, 43:1166-1174.
5. Chiesa R., Astore D., Piccolo G., Melissano G., Jannello A., Frigerio D., et al. Fresh and cryopreserved arterial homografts in the treatment of prosthetic graft infections: experience of the Italian Collaborative Vascular Homograft Group. Ann Vasc Surg 1998, 12:457-462.
6. Seeger J.M. Management of patients with prosthetic vascular graft infection. Am Surg 2000, 66:166-177.
7. Hayes P.D., Nasim A., London N.J.M., Sayers R.D., Barrie W.W., Bell P.R.F., et al. In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998). J Vasc Surg 1999, 30:92-98.
8. BSAC Steering Group. Treatment of hospital infections-prosthetic vascular graft infections. []. http://www.bsac.org.uk/pyxis/.
9. Girard C., Steinmetz E. Epidémiologie, prévention et traitement des infections de prothèses vasculaires. Conférences d'actualisation de la Société Française d'anesthésie et réanimation 2003, Elsevier, pp. 575-586.
10. Comité de l'Antibiogramme de la Société Française de Microbiologie Report. Int J Antimicrob Agents 2003, 21:364-391.
11. Copeland G.P., Jones D., Walters M. POSSUM: a scoring system for surgical audit. Br J Surg 1991, 78:356-360.
12. McCabe W.R., Jackson C.G. Gram-negative bacteremia: etiology and ecology. Arch Intern Med 1962, 110:847-855.
13. Le Gall J.R., Lemeshow S., Saulnier F. A new simplified acute physiology score (SAPS II) based on a European / North American multicenter study. JAMA 1993, 270:2957-2963.
14. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonça A., Bruining H., et al. The SOFA (Sepsis-related organ failure Assessment) score to describe organ dysfunction / failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710.
15. Ali A.T., Modrall J.G., Hocking J., Valentine R.J., Spencer H., Eidt J.F., et al. Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts. J Vasc Surg 2009, 50:30-39.
16. Kieffer E., Gomes D., Chiche L., Fléron M.H., Koskas F., Bahnini A. Allograft replacement for infrarenal aortic graft infection: early and late results in 179 patients. J Vasc Surg 2004, 39:1009-1017.
17. Zhou W., Lin P.H., Bush R.L., Terramani T.T., Matsuura J.H., Cox M., et al. In situ reconstruction with cryopreserved arterial allografts for management of mycotic aneurysms or aortic prothetic graft infections: a multi-institutional experience. Tex Heart Inst J 2006, 33:14-18.
18. Seeger J.M., Pretus H.A., Burress Welborn M., Keith Ozaki C., Flynn T.C., Huber T.S. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. J Vasc Surg 2000, 32:451-461.
19. Yeager R.A., Taylor L.M., Moneta G.L., Edwards J.M., Nicoloff A.D., McConnell D.B., et al. Improved results with conventional management of infrarenal aortic infection. J Vasc Surg 1999, 30:76-83.
20. Bandyk D.F., Novotney M.L., Back M.R., Johnson B.L., Schmacht D.C. Expanded application of in situ replacement for prosthetic graft infection. J Vasc Surg 2001, 34:411-420.
21. Stone P.A., Armstrong P.A., Bandyk D.F., Brumberg R.S., Flaherty S.K., Back M.R., et al. Use of antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary prosthetic vascular graft infections. J Vasc Surg 2006, 44:757-761.
22. Calligaro K.D., Veith F.J., Schwartz M.L., Goldsmith J., Savarese R.P., Dougherty M.J., et al. Selective preservation of infected prosthetic arterial grafts. Analysis of a 20-year experience with 120 extracavitary-infected grafts. Ann Surg 1994, 220:461-469.
23. O'Connor S., Andrew P., Batt M., Becquemin J.P. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg 2006, 44:38-45.
24. Lesèche G., Castier Y., Petit M.D., Bertrand P., Kitzis M., Mussot S., et al. Long-term results of cryopreserved arterial allograft reconstruction in infected prosthetic grafts and mycotic aneurysms of the abdominal aorta. J Vasc Surg 2001, 34:616-622.
25. Noel A.A., Gloviczki P., Cherry K.J., Safi H., Goldstone J., Morasch M.D., et al. Abdominal aortic reconstruction in infected fields: early results of the United States cryopreserved aortic allograft registry. J Vasc Surg 2002, 35:847-852.
26. Teebken O.E., Pichimaier M.A., Brand S., Haverich A. Cryopreserved arterial allografts for in situ reconstruction of infected arterial vessels. Eur J Vasc Endovasc Surg 2004, 27:597-602.
27. Brown K.E., Heyer K., Rodriguez H., Eskandari M.K., Pearce W.H., Morasch M.D. Arterial reconstruction with cryopreserved human allografts in the setting of infection: a single-center experience with midterm follox-up. J Vasc Surg 2009, 49:660-666.
28. Batt M., Jean-Baptiste E., O'Connor S., Bouillanne P.J., Haudebourg P., Hassen-Khodja R., et al. In-situ revascularisation for patients with aortic graft infection: a single centre experience with silver coated polyester grafts. Eur J Vasc Endovasc Surg 2008, 36:182-188.
29. Clagett G.P., Valentine R.J., Hagino R.T. Autogenous aortoiliac/femoral reconstruction from superficial femoral popliteal veins: feasibility and durability. J Vasc Surg 1997, 25:255-266.
30. Leone M., Bourgoin A., Cambon S., Dubuc M., Albanèse J., Martin C. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med 2003, 31:462-467.
31. Lesens O., Brannigan E., Bergin C., Christmann D., Hansmann Y. Impact of the use of aminoglycosides in combination antibiotic therapy on septic shock and mortality due to Staphylococcus aureus bacteremia. Eur J Intern Med 2006, 17:276-280.
32. Mical P., Benuri-Silbiger I., Soares-Weiser K., Leibovici L. β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 2004, 328:668-672.